Screening

17 articles
by James Dickinson Harminder Singh Roland Grad

Why screening guideline committees should not include ‘experts’ as voting members

The challenge to those who do not like the Canadian Task Force recommendations is this: Can you provide or research the new evidence required to show how a different policy is better?

by Anne Borden King Michelle Cohen

Increase in online ADHD diagnoses for kids poses ethical questions

During the pandemic, Ontario swapped out in-clinic ADHD assessment and prescriptions for a virtual care model. Should we continue allowing it for kids?

by Tara Slade-Hall

OurCare Quebec: ‘Patients are frustrated and afraid of what is to come’

Like most Quebecers, I'm worried about our failing health-care system. We as patients are left feeling frustrated and afraid of what is to come.

by Nicole Naimer

Clinic offers a ‘one-stop shop’ for brain care

The Brain Medicine Clinic – a novel clinical model that is a “one-stop shop” for diagnosis, symptom management and treatment – is serving those who don’t have a clear home elsewhere in the health-care system.

by Ryan Chadwick Jolie Leung Emily Block Larry W. Chambers

Anxiety vs. stress: The right definition will lead to better mental-health care

Conflating stress and anxiety in medical settings can have serious implications for patients. New research on "social prescribing" could pave the way for more effective treatment.

by Shushiela Appavoo

Excluding experts doesn’t make sense

Most assume that the Canadian task force guidelines are led by content expert specialist clinicians. But this is not the case. The task force says it excludes content experts from genuine involvement in guideline development to avoid conflicts of interest. However, in the Canadian health-care context, this is not a valid argument.

by Sandor J. Demeter

Lung-cancer screening – primum non nocere (first, do no harm)!

Lung cancer is the number one global killer among cancers. Early detection can help patients' chance of survival but current screening measures also come with mixed benefits and risks.

by Joanne Kotsopoulos Steve Narod

We have the tools to prevent ovarian cancer. Why aren’t we using them?

About 20 per cent of the ovarian cancer cases in Canada diagnosed each year are in people who carry a mutation and are most likely preventable. Genetic testing can become more accessible. Why are we waiting? 

by Maddi Dellplain

How should we handle the toxic drug-supply crisis? Experts weigh in.

While political debates have muddied the water on effective policy options to address toxic drug deaths, we asked a panel of experts what they see as the best path forward to address the ongoing crisis.

by Anne Borden King

Trust us to make our own decisions about breast-cancer screenings

The new U.S. guidance on breast-cancer screening shouldn’t be controversial or a “both sides” issue in Canada. It should serve as a model for the change we need.

by David Campbell

Emergency brain surgery showed me the best of Ontario health care – and the worst

It’s true that when faced with a crisis, some of the best health-care professionals in the world are available to care for us. But that system is at its breaking point.

by Anne Borden King

Having breast cancer impacts sexuality: Why don’t we talk about it?

It's common for women to struggle with sexual health issues after breast cancer. But it isn’t just our bodies that change; the experience of cancer changes our relationship with time, aging and even the arc of life that we imagine for ourselves.

by Laura Syron

Odds are there is a woman in your life living with diabetes – she deserves better research

As the world celebrates another International Women’s Day, we should reflect on what gender equality really means. Science and research needs to adequately address women's health needs.

by Swetha Raman Chakravarthy Dora Mugambi Karim Keshavjee

Addressing a blind spot in care for patients living with diabetes

The sudden decline in diabetes screening as a result of the pandemic has put a significant number of Ontarians in danger of vision loss. Unchecked, this problem is associated with a massive cost for the government and society. But this can be avoided with a proactive screening strategy.

by Maddi Dellplain

Will the first cut be the deepest? The debate on for-profit surgeries

As Ontario moves to fund private centres for select surgical procedures, will the province see a reduction in backlogs? Or is it a slippery slope towards further privatization of the provincial healthcare system? Our experts weigh in.

by Sandor J. Demeter

Behind the scenes: The increasingly complex – and common – radiation treatment for cancer

Radiation therapy for cancer is becoming increasingly complex, sophisticated and personalized. Behind the scenes for most patients hides an invisible team hard at work.

1 of 1